Abbott Laboratories (ABT) Interest Expenses (2009 - 2026)
Abbott Laboratories (ABT) posted Interest Expenses of $1.5 billion for Q2 2026, little changed sequentially from $1.5 billion in Q1 2026, and up 40.71% YoY from $1.1 billion in Q2 2025.
Abbott Laboratories (ABT) Interest Expenses (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Interest Expenses for 18 years, with the latest figure at $1.5 billion in Q2 2026.
- Quarterly Interest Expenses rose 40.71% year-over-year to $1.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.5 billion (up 40.71% YoY) and the FY2025 annual result came in at $9.7 billion, down 6.02% from the prior year.
- Interest Expenses was little changed at $1.5 billion in Q2 2026 per ABT's latest filing, from $1.5 billion in the prior quarter.
- Over five years, Interest Expenses peaked at $1.6 billion in Q1 2022 and troughed at $120.0 million in Q4 2025.
- A 5-year average of $1.0 billion and a median of $1.1 billion in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2026: Interest Expenses sank 37.31% in 2024, then surged 44.93% in 2026.
- Over 5 years, Interest Expenses stood at $154.0 million in 2022, then grew by 3.25% to $159.0 million in 2023, then slipped by 14.47% to $136.0 million in 2024, then dropped by 11.76% to $120.0 million in 2025, then soared by 1150.0% to $1.5 billion in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $1.5 billion, $1.5 billion, and $120.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Bn |
| Jun 30, 2026 | 1.50 Bn |
| Mar 31, 2026 | 1.50 Bn |
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 120.00 Mn |
| Dec 31, 2025 | 120.00 Mn |
| Sep 30, 2025 | 995.00 Mn |
| Sep 30, 2025 | 995.00 Mn |
| Jun 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.04 Bn |
| Dec 31, 2024 | 136.00 Mn |
| Dec 31, 2024 | 136.00 Mn |
| Sep 30, 2024 | 952.00 Mn |
| Sep 30, 2024 | 952.00 Mn |
| Jun 30, 2024 | 815.00 Mn |
| Jun 30, 2024 | 815.00 Mn |
| Mar 31, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.03 Bn |